Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Jason Alger is Chief Financial Officer at Health Catalyst. OQRO lists 8 transactions filed with the SEC under this name, the latest on Sep 4, 2026, each linked to the official Form 4.
Chief Financial Officer
Disclosures on record
8
Companies involved
1
Jason Alger has no open-market purchase on record since 2021. Sales in 4 of the 6 years since 2021.
Jason Alger reported 0 open-market purchases and 16 sales since 2021; no open-market purchase.
| Year | Bought | Sold |
|---|---|---|
| 2024 | — | $204K3×3 trades |
| 2023 | — | $112K4×4 trades |
| 2022 | — | $21K4×4 trades |
| 2021 | — | $439K5×5 trades |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
Health CatalystHCAT
8 disclosures · Dec 2024 – Sep 2026 · 1 sold
Sep 1, 202618Kdisclosed Sep 4
DetailsOfficial recordJun 1, 202619Kdisclosed Jun 4
DetailsOfficial recordMar 2, 202627Kdisclosed Mar 6
DetailsOfficial recordFeb 25, 2026508Kdisclosed Feb 28
DetailsOfficial recordFeb 25, 202622Kdisclosed Feb 28
DetailsOfficial recordFeb 26, 20267,522disclosed Feb 28
DetailsOfficial recordDec 1, 202521Kdisclosed Dec 4
DetailsOfficial recordDec 6, 2024Sold~$163Kdisclosed Dec 10
DetailsOfficial recordAs of the latest filing on , Jason Alger reported holding 704,867 shares of Health Catalyst (HCAT), worth about $1.06M at the last close of $2 (Nov 13, 2026).
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Health Catalyst HCAT | 704,867 | 705K direct | $2 | $1.06M | Sep 1, 2026 |
Is this Jason Alger’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
Jason Alger reported 0 open-market purchases and 16 sales here, 2021 to 2024.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.
On the latest SEC Form 4, dated Sep 1, 2026, Jason Alger reported holding 704,867 shares of Health Catalyst (HCAT). At the last close of $2 on Nov 13, 2026, that is about $1.06M. This is the stake disclosed in filings, not a net worth.
Jason Alger has no open-market purchase on record since 2021. Sales in 4 of the 6 years since 2021.
In SEC filings since 2021: no open-market purchase is on record; the latest open-market sale is from 2024.
Health Catalyst (HCAT), from 2021 to 2024: 0 purchases and 16 sales.